Reconstructing the functional effect of TP53 somatic mutations on its regulon using causal signalling network modelling

Abstract

AO_SCPLOWBSTRACTC_SCPLOWThe gene encoding tumor protein p53 (TP53) is the most frequently mutated gene in human cancer. Mutations in both coding and non-coding regions of TP53 can disrupt the regulatory function of the transcription factor, but the functional impact of different somatic mutations on the global TP53 regulon is complex and poorly understood. To address this, we first proceed with a machine learning (ML) approach, and then propose an integrated computational network modelling approach that reconstructs signalling networks using a comprehensive collection of experimental and predicted regulons, and compares their topology. We evaluate both these approaches in a scrutinized pan-cancer analysis of matched genomics and transcriptomics data from 1,457 cell lines (22 cancer types) and 12,531 clinical samples (54 cancer sub-types). Using a ML approach based on penalized generalized linear regression we were able to predict TP53 mutation, but failed to resolve different mutation types. Thus, to infer the impact of different TP53 mutations we compared the topological characteristics of the optimized and reconstructed (upwards of twenty thousand) gene networks and extracted gene signatures for each mutation type using network analysis. We demonstrate that by accounting for TP53 mutation characteristics such as i) mutation type (e.g. missense, nonsense), ii) deleterious consequences of the mutation, or iii) mapping to previously identified hotspots, we can infer a much richer understanding of gene expression regulation, than when simply grouping samples based on their mutation/wild type or gene expression status. Our study highlights a powerful strategy exploiting signalling networks to systematically characterize the functional impact of the full spectrum of somatic mutations. This approach can be applied in general to genetic variation, with clear implications for, but not limited to, the biomedical domain and precision medicine.